XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock Class B
Common Stock
Common Stock Class A
Common Stock
Common Stock Class B
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021       170,625,994 9,842,105      
Beginning balance at Dec. 31, 2021 $ 11,031,466     $ 168 $ 12 $ 13,169,118 $ (18,141) $ (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (221,627)             (221,627)
Exercises of vested stock options (in shares)       180,643 193,889      
Exercises of vested stock options 11,727         11,727    
Vesting of restricted stock units (in shares)       877,089        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (5,804)        
Value of equity awards withheld for tax liability (1,065)         (1,065)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       215,389 (215,389)      
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 4,232         4,232    
Shares returned from escrow (in shares)       (152,239)        
Shares returned from escrow (387)         (387)    
Unrealized gain (loss) on marketable securities (62,826)           (62,826)  
Foreign currency translation (165)           (165)  
Net change in market value of effective foreign currency forward exchange contracts (3,852)           (3,852)  
Stock-based compensation 159,930         159,930    
Ending balance (in shares) at Mar. 31, 2022       171,763,174 9,820,605      
Ending balance at Mar. 31, 2022 10,917,433     $ 169 $ 12 13,343,554 (84,984) (2,341,318)
Beginning balance (in shares) at Dec. 31, 2021       170,625,994 9,842,105      
Beginning balance at Dec. 31, 2021 11,031,466     $ 168 $ 12 13,169,118 (18,141) (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (1,026,723)              
Unrealized gain (loss) on marketable securities (103,999)              
Foreign currency translation (4,646)              
Net change in market value of effective foreign currency forward exchange contracts (34,154)              
Share of other comprehensive income (loss) from equity method investment (4,243)              
Ending balance (in shares) at Sep. 30, 2022       174,482,722 9,817,605      
Ending balance at Sep. 30, 2022 10,530,888     $ 172 $ 12 13,842,301 (165,183) (3,146,414)
Beginning balance (in shares) at Mar. 31, 2022       171,763,174 9,820,605      
Beginning balance at Mar. 31, 2022 10,917,433     $ 169 $ 12 13,343,554 (84,984) (2,341,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (322,769)             (322,769)
Exercises of vested stock options (in shares)       98,111 77,732      
Exercises of vested stock options 5,649         5,649    
Vesting of restricted stock units (in shares)       1,049,640        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (38)        
Value of equity awards withheld for tax liability (4)         (4)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       80,732 (80,732)      
Shares issued under ESPP (in shares)       258,221        
Shares issued under ESPP 24,318     $ 1   24,317    
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 2,373         2,373    
Unrealized gain (loss) on marketable securities (19,022)           (19,022)  
Foreign currency translation (2,289)           (2,289)  
Net change in market value of effective foreign currency forward exchange contracts (11,106)           (11,106)  
Stock-based compensation 247,412         247,412    
Ending balance (in shares) at Jun. 30, 2022       173,271,942 9,817,605      
Ending balance at Jun. 30, 2022 10,841,995     $ 171 $ 12 13,623,300 (117,401) (2,664,087)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (482,327)             (482,327)
Exercises of vested stock options (in shares)       38,368 35,187      
Exercises of vested stock options 2,056         2,056    
Vesting of restricted stock units (in shares)       1,115,248        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (125)        
Value of equity awards withheld for tax liability (11)         (11)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       35,187 (35,187)      
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,911         1,911    
Unrealized gain (loss) on marketable securities (22,151)           (22,151)  
Foreign currency translation (2,192)           (2,192)  
Net change in market value of effective foreign currency forward exchange contracts (19,196)           (19,196)  
Share of other comprehensive income (loss) from equity method investment (4,243)           (4,243)  
Stock-based compensation 199,772         199,772    
Stock-based compensation - restructuring 15,274         15,274    
Ending balance (in shares) at Sep. 30, 2022       174,482,722 9,817,605      
Ending balance at Sep. 30, 2022 10,530,888     $ 172 $ 12 13,842,301 (165,183) (3,146,414)
Beginning balance (in shares) at Dec. 31, 2022   176,358,104 9,617,605 176,358,104 9,617,605      
Beginning balance at Dec. 31, 2022 10,559,042     $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (342,139)             (342,139)
Exercises of vested stock options (in shares)       66,968 97,199      
Exercises of vested stock options 3,264         3,264    
Vesting of restricted stock units (in shares)       1,516,634        
Vesting of restricted stock units 0     $ 2   (2)    
Value of equity awards withheld for tax liability (in shares)       (36,965)        
Value of equity awards withheld for tax liability (2,456)         (2,456)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       97,199 (97,199)      
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,599         1,599    
Unrealized gain (loss) on marketable securities 30,750           30,750  
Repurchases of shares of Class A common stock including related costs (in shares)       (1,902,124)        
Repurchases of shares of Class A common stock including related costs (124,992)     $ (2)       (124,990)
Foreign currency translation 483           483  
Net change in market value of effective foreign currency forward exchange contracts 3,335           3,335  
Share of other comprehensive income (loss) from equity method investment 14,648           14,648  
Stock-based compensation 164,999         164,999    
Stock-based compensation - restructuring 10,333         10,333    
Ending balance (in shares) at Mar. 31, 2023       176,121,918 9,617,605      
Ending balance at Mar. 31, 2023 10,318,866     $ 174 $ 12 14,233,590 (71,945) (3,842,965)
Beginning balance (in shares) at Dec. 31, 2022   176,358,104 9,617,605 176,358,104 9,617,605      
Beginning balance at Dec. 31, 2022 10,559,042     $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (650,033)              
Unrealized gain (loss) on marketable securities $ 53,276              
Repurchases of shares of Class A common stock including related costs (in shares) (9,200,000)              
Foreign currency translation $ 5,587              
Net change in market value of effective foreign currency forward exchange contracts (7,458)              
Share of other comprehensive income (loss) from equity method investment 17,030              
Ending balance (in shares) at Sep. 30, 2023   182,066,098 0 182,066,098 0      
Ending balance at Sep. 30, 2023 9,979,381     $ 182 $ 0 14,610,887 (52,726) (4,578,962)
Beginning balance (in shares) at Mar. 31, 2023       176,121,918 9,617,605      
Beginning balance at Mar. 31, 2023 10,318,866     $ 174 $ 12 14,233,590 (71,945) (3,842,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (166,187)             (166,187)
Exercises of vested stock options (in shares)       33,438 30,783      
Exercises of vested stock options 1,477         1,477    
Vesting of restricted stock units (in shares)       1,144,112        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (872)        
Value of equity awards withheld for tax liability (53)         (53)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       9,648,388 (9,648,388)      
Conversion of shares of Class B common stock into shares of Class A common stock 0     $ 12 $ (12)      
Shares issued under ESPP (in shares)       579,857        
Shares issued under ESPP 23,337         23,337    
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,047         1,047    
Unrealized gain (loss) on marketable securities 8,605           8,605  
Repurchases of shares of Class A common stock including related costs (in shares)       (6,374,327)        
Repurchases of shares of Class A common stock including related costs (373,147)     $ (6)       (373,141)
Foreign currency translation 86           86  
Net change in market value of effective foreign currency forward exchange contracts (2,167)           (2,167)  
Share of other comprehensive income (loss) from equity method investment 5,146           5,146  
Stock-based compensation 159,253         159,253    
Stock-based compensation - restructuring 296         296    
Ending balance (in shares) at Jun. 30, 2023       181,174,616 0      
Ending balance at Jun. 30, 2023 9,976,559     $ 181 $ 0 14,418,946 (60,275) (4,382,293)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (141,707)             (141,707)
Exercises of vested stock options (in shares)       100,000        
Exercises of vested stock options 871         871    
Vesting of restricted stock units (in shares)       1,669,596        
Vesting of restricted stock units 0     $ 2   (2)    
Value of equity awards withheld for tax liability (in shares)       (417)        
Value of equity awards withheld for tax liability (27)         (27)    
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,339         1,339    
Unrealized gain (loss) on marketable securities $ 13,921           13,921  
Repurchases of shares of Class A common stock including related costs (in shares) (900,000)     (899,799)        
Repurchases of shares of Class A common stock including related costs $ (54,963)     $ (1)       (54,962)
Foreign currency translation 5,018           5,018  
Net change in market value of effective foreign currency forward exchange contracts (8,626)           (8,626)  
Share of other comprehensive income (loss) from equity method investment (2,764)           (2,764)  
Stock-based compensation 189,293         189,293    
Stock-based compensation - restructuring 467         467    
Ending balance (in shares) at Sep. 30, 2023   182,066,098 0 182,066,098 0      
Ending balance at Sep. 30, 2023 $ 9,979,381     $ 182 $ 0 $ 14,610,887 $ (52,726) $ (4,578,962)